{
    "paper_id": "16cbc30ba04eaeaed964386b1c0a85fad245f52f",
    "metadata": {
        "title": "Journal Pre-proof A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 2 admitted hospital patients",
        "authors": [
            {
                "first": "Lei",
                "middle": [],
                "last": "Liu",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command of PLA",
                    "location": {
                        "addrLine": "11 Wuhan 430070",
                        "settlement": "Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Wanbing",
                "middle": [],
                "last": "Liu",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command of PLA",
                    "location": {
                        "addrLine": "11 Wuhan 430070",
                        "settlement": "Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Yaqiong",
                "middle": [],
                "last": "Zheng",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command of PLA",
                    "location": {
                        "addrLine": "11 Wuhan 430070",
                        "settlement": "Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Xiaojing",
                "middle": [],
                "last": "Jiang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command 13 of PLA",
                    "location": {
                        "postCode": "430070",
                        "settlement": "Wuhan, Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Guomei",
                "middle": [],
                "last": "Kou",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command of PLA",
                    "location": {
                        "addrLine": "11 Wuhan 430070",
                        "settlement": "Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Jinya",
                "middle": [],
                "last": "Ding",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Qiongshu",
                "middle": [],
                "last": "Wang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central",
                    "location": {
                        "addrLine": "Theater 17 Command of PLA",
                        "postCode": "430070",
                        "settlement": "Wuhan, Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Qianchuan",
                "middle": [],
                "last": "Huang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central",
                    "location": {
                        "addrLine": "Theater Command 15 of PLA",
                        "postCode": "430070",
                        "settlement": "Wuhan, Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Yinjuan",
                "middle": [],
                "last": "Ding",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command of PLA",
                    "location": {
                        "addrLine": "11 Wuhan 430070",
                        "settlement": "Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Wenxu",
                "middle": [],
                "last": "Ni",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command of PLA",
                    "location": {
                        "addrLine": "11 Wuhan 430070",
                        "settlement": "Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Wanlei",
                "middle": [],
                "last": "Wu",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command of PLA",
                    "location": {
                        "addrLine": "11 Wuhan 430070",
                        "settlement": "Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Shi",
                "middle": [],
                "last": "Tang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command of PLA",
                    "location": {
                        "addrLine": "11 Wuhan 430070",
                        "settlement": "Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Li",
                "middle": [],
                "last": "Tan",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central",
                    "location": {
                        "addrLine": "Theater 17 Command of PLA",
                        "postCode": "430070",
                        "settlement": "Wuhan, Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Zhenhong",
                "middle": [],
                "last": "Hu",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command 13 of PLA",
                    "location": {
                        "postCode": "430070",
                        "settlement": "Wuhan, Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Weitian",
                "middle": [],
                "last": "Xu",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command 13 of PLA",
                    "location": {
                        "postCode": "430070",
                        "settlement": "Wuhan, Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Yong",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command 13 of PLA",
                    "location": {
                        "postCode": "430070",
                        "settlement": "Wuhan, Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Bo",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command 13 of PLA",
                    "location": {
                        "postCode": "430070",
                        "settlement": "Wuhan, Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Zhongzhi",
                "middle": [],
                "last": "Tang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Xinhua",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Honghua",
                "middle": [],
                "last": "Li",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command 13 of PLA",
                    "location": {
                        "postCode": "430070",
                        "settlement": "Wuhan, Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Zhiguo",
                "middle": [],
                "last": "Rao",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command 13 of PLA",
                    "location": {
                        "postCode": "430070",
                        "settlement": "Wuhan, Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Hui",
                "middle": [],
                "last": "Jiang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command 13 of PLA",
                    "location": {
                        "postCode": "430070",
                        "settlement": "Wuhan, Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Xingfeng",
                "middle": [],
                "last": "Ren",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command 13 of PLA",
                    "location": {
                        "postCode": "430070",
                        "settlement": "Wuhan, Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Shengdian",
                "middle": [],
                "last": "Wang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command 13 of PLA",
                    "location": {
                        "postCode": "430070",
                        "settlement": "Wuhan, Hubei",
                        "country": "China"
                    }
                },
                "email": "sdwang@ibp.ac.cn"
            },
            {
                "first": "Shangen",
                "middle": [],
                "last": "Zheng",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command of PLA",
                    "location": {
                        "addrLine": "11 Wuhan 430070",
                        "settlement": "Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "L",
                "middle": [],
                "last": "Liu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "W",
                "middle": [],
                "last": "Liu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Y",
                "middle": [],
                "last": "Zheng",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "X",
                "middle": [],
                "last": "Jiang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "G",
                "middle": [],
                "last": "Kou",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "J",
                "middle": [],
                "last": "Ding",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Q",
                "middle": [],
                "last": "Wang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Q",
                "middle": [],
                "last": "Huang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Y",
                "middle": [],
                "last": "Ding",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "W",
                "middle": [],
                "last": "Ni",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "W",
                "middle": [],
                "last": "Wu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "S",
                "middle": [],
                "last": "Tang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "L",
                "middle": [],
                "last": "Tan",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Z",
                "middle": [],
                "last": "Hu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "W",
                "middle": [],
                "last": "Xu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Y",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "B",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Z",
                "middle": [],
                "last": "Tang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "X",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "H",
                "middle": [],
                "last": "Li",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Z",
                "middle": [],
                "last": "Rao",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "H",
                "middle": [],
                "last": "Jiang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "X",
                "middle": [],
                "last": "Ren",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "S",
                "middle": [],
                "last": "Wang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "S",
                "middle": [],
                "last": "Zheng",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central",
                    "location": {
                        "addrLine": "Theater Command 15 of PLA",
                        "postCode": "430070",
                        "settlement": "Wuhan, Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Jinya",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Ding",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central",
                    "location": {
                        "addrLine": "Theater Command 15 of PLA",
                        "postCode": "430070",
                        "settlement": "Wuhan, Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Zhongzhi",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Tang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "General Hospital of Central Theater Command 13 of PLA",
                    "location": {
                        "postCode": "430070",
                        "settlement": "Wuhan, Hubei",
                        "country": "China"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients, Microbes and Infection, https://doi.31 suspected patients were most likely infected by SARS-CoV-2. Before the 11th day 48 after initial onset of symptoms, nucleic acid test is key for confirmation of viral 49 infection. The combination of serological assay can greatly improve the diagnostic 50 efficacy. After the 11th day post-disease onset, the diagnosis for viral infection should 51 be majorly dependent on serological assay.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "52",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "In this study, we aimed to evaluate the diagnostic value of serological assay for 34 SARS-CoV-2. A newly-developed ELISA assay for IgM and IgG antibodies against N 35 protein of SARS-CoV-2 was used to screen the serums of 238 admitted hospital 36 patients between February 6 and February 14, 2020 with confirmed or suspected 37 SARS-CoV-2. SARS-CoV-2 RNA was detected on pharyngeal swab specimens using 38 real time RT-PCR. 194 (81.5%) of the serums were detected to be antibody (IgM 39 and/or IgG) positive, significantly higher than the positive rate of viral RNA (64.3%). 40 There was no difference in the positive rate of antibodies between the confirmed 41 patients (83.0%, 127/153) and the suspected patients (78.8%, 67/85), whose nucleic 42 acid tests were negative. The antibody positive rates were very low in the first five 43 days after initial onset of symptoms, and then rapidly increased as the disease 44 progressed. After 10 days, the antibody positive rates jumped from below 50% to over 45 80%. However, the positive rates of viral RNA maintained above 60% in the first 11 46 days after initial onset of symptoms, and then rapidly decreased. Overall, the 47 1. Introduction 55 A novel betacoronavirus [1] , named severe acute respiratory syndrome 56 coronavirus 2 (SARS-CoV-2), caused a number of respiratory illness cases, known as positive for viral RNA using real time RT-PCR assay on pharyngeal swab specimens. 105 The remaining 85 patients, who had negative results from the real time RT-PCR assay, 106 were clinically diagnosed as highly-suspected cases according to the notice on the 50 healthy blood donors. The study was approved by the Hospital Ethics Committee 119 and written informed consent was waived for emerging infectious diseases. 215 To study the diagnostic value of ELISA assay for virus-specific antibodies, (Table 2) . Due to having a low number of 224 samples for each individual day, we pooled the samples in which the positive rates 225 were similar in consecutive days. Thus, the disease process was divided into five 226 phases of 0-5 days, 6-10 days,11-12 days, 13-15 days and more than 16 days after 227 initial onset of symptoms (Table 3 & Fig.2) . The data show that the positive rates of 228 IgM and/or IgG are extremely low in the first five days after initial onset of symptoms 229 because no antibodies are produced in the majority of patients at this early stage, and rapidly increase as the disease progresses. Day 11 after initial onset of symptoms is a 231 key point because the positive rates of IgM and/or IgG jump to over 80% from less 232 than 50%. The sensitivity of antibody detection reaches to more than 93% since day 233 11 after initial onset of symptoms. This dynamic trend is consistent with SARS-CoV 234 infection [22] . In comparison, the real-time RT-PCR was more effective for detecting 235 SARS-CoV-2 infection than ELISA in the early stage of the disease. The positive rate 236 of viral RNA detected by RT-PCR was maintained above 60% in the first 11 days after 237 initial onset of symptoms, and rapidly decreased with the rapid increase of antibodies. 238 These results demonstrate that ELISA-based IgM and/or IgG detection should be used 239 as a major viral diagnostic test for patients with symptoms for more than 10 days. 240 Given that 50% of clinically suspected patients with symptoms for 6-10 days were 241 detected to be positive by ELISA-based IgM and/or IgG detection (Table 4) ",
            "cite_spans": [
                {
                    "start": 82,
                    "end": 84,
                    "text": "34",
                    "ref_id": null
                },
                {
                    "start": 244,
                    "end": 246,
                    "text": "36",
                    "ref_id": null
                },
                {
                    "start": 403,
                    "end": 405,
                    "text": "38",
                    "ref_id": null
                },
                {
                    "start": 484,
                    "end": 486,
                    "text": "39",
                    "ref_id": null
                },
                {
                    "start": 575,
                    "end": 577,
                    "text": "40",
                    "ref_id": null
                },
                {
                    "start": 834,
                    "end": 836,
                    "text": "43",
                    "ref_id": null
                },
                {
                    "start": 917,
                    "end": 919,
                    "text": "44",
                    "ref_id": null
                },
                {
                    "start": 1091,
                    "end": 1093,
                    "text": "46",
                    "ref_id": null
                },
                {
                    "start": 1219,
                    "end": 1222,
                    "text": "[1]",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 1265,
                    "end": 1267,
                    "text": "56",
                    "ref_id": null
                },
                {
                    "start": 1433,
                    "end": 1436,
                    "text": "105",
                    "ref_id": null
                },
                {
                    "start": 1522,
                    "end": 1525,
                    "text": "106",
                    "ref_id": null
                },
                {
                    "start": 1768,
                    "end": 1771,
                    "text": "215",
                    "ref_id": null
                },
                {
                    "start": 1977,
                    "end": 1980,
                    "text": "225",
                    "ref_id": null
                },
                {
                    "start": 2239,
                    "end": 2242,
                    "text": "228",
                    "ref_id": null
                },
                {
                    "start": 2785,
                    "end": 2789,
                    "text": "[22]",
                    "ref_id": null
                },
                {
                    "start": 3130,
                    "end": 3133,
                    "text": "238",
                    "ref_id": null
                },
                {
                    "start": 3304,
                    "end": 3307,
                    "text": "240",
                    "ref_id": null
                }
            ],
            "ref_spans": [
                {
                    "start": 1848,
                    "end": 1857,
                    "text": "(Table 2)",
                    "ref_id": "TABREF2"
                },
                {
                    "start": 2178,
                    "end": 2188,
                    "text": "(Table 3 &",
                    "ref_id": "TABREF3"
                },
                {
                    "start": 2189,
                    "end": 2195,
                    "text": "Fig.2)",
                    "ref_id": "FIGREF14"
                },
                {
                    "start": 3457,
                    "end": 3466,
                    "text": "(Table 4)",
                    "ref_id": "TABREF4"
                }
            ],
            "section": "Abstract"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Genomic characterisation and epidemiology of 305 2019 novel coronavirus: implications for virus origins and receptor binding",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Niu",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "IgM, and IgA antibodies against the severe acute respiratory syndrome 347 (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Emerging coronaviruses: Genome structure, replication",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Serological Assays for 352 SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Infantino",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Damiani",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "L"
                    ],
                    "last": "Gobbi",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Grossi",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Lari",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Macchia",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Isr Med Assoc J",
            "volume": "353",
            "issn": "2020",
            "pages": "203--213",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "General Office of National Health Committee & Office of State Administration of Traditional 355",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Chinese Medicine. Notice on the issuance of strategic guidelines for diagnosis and treatment of novel 356 coronavirus (2019-nCoV) infected pneumonia",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Double-antigen sandwich ELISA for 359 detection of antibodies to SARS-associated coronavirus in human serum",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Che",
                    "middle": [
                        "J"
                    ],
                    "last": "Yin",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Eur J Clin Microbiol Infect",
            "volume": "360",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Antibody responses to SARS-CoV-2 in 362 patients of novel coronavirus disease 2019",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Liao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Su",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Clin",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Profiling early humoral response to diagnose 365 novel coronavirus disease (COVID-19)",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Ren",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "Xiao",
                    "middle": [
                        "M"
                    ],
                    "last": "Chang",
                    "suffix": ""
                },
                {
                    "first": "Yang",
                    "middle": [
                        "F"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clin Infect Dis",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1093/cid/ciaa310.onlineahead"
                ]
            }
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "where N is the total number of patients with available data. P values comparing the confirmed patients and the suspected patients are from \u03c7\u00b2 test, Fisher's exact test",
            "authors": [],
            "year": null,
            "venue": "Data are median (IQR), n (%), or n/N (%)",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Day= the day after initial onset of symptoms. Viral RNA + =a positive result detected by real time RT-PCR",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "IgM + =a positive result detected by IgM ELISA and simultaneously a negative result detected by IgG ELISA. IgG + =a positive result detected by IgG ELISA and simultaneously a negative result detected by IgM ELISA. IgM + and IgG + =a dual positive result detected by IgM and IgG ELISA. IgM + and/or IgG + =at least a positive result detected by IgM and IgG ELISA",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Days= the day after initial onset of symptoms. Viral RNA + =a positive result detected by real time RT-PCR",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "IgM + =a positive result detected by IgM ELISA and simultaneously a negative result detected by IgG ELISA. IgG + =a positive result detected by IgG ELISA and simultaneously a negative result detected by IgM ELISA. IgM + and IgG + =a dual positive result detected by IgM and IgG ELISA. IgM + and/or IgG + =at least a positive result detected by IgM and IgG ELISA",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "57 corona virus disease 2019 (COVID-19), in various regions of the world. This lead to a 58 public health emergency, most severely in in Wuhan city, Hubei province, China from 59 December 2019 [2]. By April 19, 2020, more than two million confirmed cases were 60 identified globally. There is evidence that SARS-CoV-2 can transmit rapidly from 61 person to person as was the case in hospital and family settings [3-5]. 62 SARS-CoV-2 is the seventh member of the enveloped RNA coronaviruses (CoVs) 63 [6-8]. The sequence and phylogenetic tree of CoVs analysis indicates that 64 SARS-CoV-2 is genetically distinct from SARS-CoV and is more closely related to 65 bat-SL-CoV ZC45 and bat-SL-CoV ZXC21 [1]. SARS-CoV-2 has a similar 66 receptor-binding domain structure to that of SARS-CoV [1]. A typical CoV contains 67 four main structural proteins: spike (S), membrane (M), envelope (E), and 68 nucleocapsid (N",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "107issuance of strategic guidelines for diagnosis and treatment of COVID-19[21].108    Suspected cases were diagnosed as long as they had one of the following109 epidemiological history: (a) travel or residence history in Wuhan or other areas where 110 local cases continue to spread within 14 days before onset; (b) having contacted with 111 patients with fever or respiratory symptoms from Wuhan or other areas where local 112 cases continue to spread within 14 days before onset; (c) epidemiologically relevant to 113 cluster disease or people infected with SARS-CoV-2, and two of the following clinical 114 manifestations: (a) fever; (b) chest imaging features; (c) normal or decreased white 115 blood cell count in the early stage of onset, or decreased lymphocyte count. The 116 serum samples were collected once from each recruited patient. Meanwhile, the 117 control consisted of serum samples randomly selected from 70 ordinary patients and 118",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "with 200 \u03bcL of virus preservation solution. Total RNA was extracted 123 using the respiratory sample RNA isolation kit (Shuoshi, Shanghai, China). After 124 vortex, 50 \u03bcL of cell lysates were transferred into another collection tube. The 125 collection tube was centrifugated at 1000 rpm/min for 5 min after standing at room 126 temperature for 10 minutes. 5 \u03bcL RNA was prepared and used for real time RT-PCR. 127 Real time RT-PCR was performed using the nucleic acid testing kit (Daan, 128 Guangzhou, China) for SARS-CoV-2 detection. The open reading frame 1ab 129 (ORF1ab) and nucleocapsid protein (N) were simultaneously selected as the two 130 target genes. The human GAPDH gene was used as an internal control. The specific 131 primers and probes set for ORF1ab and N were as follows: ORF1ab--VIC-TCCTGCTAGAATGGCTGGCAATGGCG-BHQ1-3'. The real time RT-PCR 138 experiment was thoroughly performed according to the kit's instructions. The reaction 139 mixture contains 17 \u03bcL of reaction buffer A, 3 \u03bcL of reaction buffer B, and 5 \u03bcL RNA 140 template. The real time RT-PCR assay was performed under the following conditions: 141 incubation at 50 \u00b0C for 15 min and 95 \u00b0C for 15 min, 45 cycles of denaturation at 94 \u00b0C for 15 s, and extension and collection of fluorescence signal at 55 \u00b0C for 45 s. Enzyme-Linked Immunosorbent Assay (ELISA) 146 Serological assay was performed using an Enzyme-Linked Immunosorbent Assays 147 kit (Lizhu, Zhuhai, China ), which was developed for detecting IgM or IgG antibody 148 against N proteins of SARS-CoV-2. For IgM detection, ELISA plates were previously 149 coated with mouse anti-human IgM (\u03bc chain) monoclonal antibody. 100 \u03bcL of diluted 150 (1:100) serum sample was added to the pre-coated plates with three replicating wells 151 for each sample and incubated at 37 \u00b0C for 1 h. The heat-inactivated positive and 152 negative serums were included on each plate. After washing, 100 \u03bcL of horse radish 153 peroxidase (HRP) conjugated recombinant (rN) protein of SARS-CoV-2 were added. 154 The plate was incubated at 37 \u00b0C for 30 min and then washed. 50 \u03bcL of TMB 155 substrate solution and 50 \u03bcL of the corresponding buffer were added and incubated at 156 37 \u00b0C for 15 min. The reaction was terminated by adding 50 \u03bcL of 2 M sulfuric acid, 157 and the absorbance value at 450 nm (A 450 ) was determined. The cut off value was 158 calculated using the sum of 0.100 and average A 450 of the negative control replicates. 159 A 450 less than cut off value was defined as a negative test, and A 450 greater than or 160 equal to cut off value was defined as a positive test. 161 For IgG detection, ELISA plates were previously coated with rN protein. 5 \u03bcL of 162 serum sample diluted with 100 \u03bcL of dilution buffer were added to the plates. After 163 incubation and washing, HRP-conjugated mouse anti-human IgG monoclonal antibody was added to the plates for detection. The other operational steps were 165 performed as described in the above IgM detection. The cut off value was calculated 166 using the sum of 0.130 and average A 450 of the negative control replicates. A 450 less 167 than cut off value was defined as a negative test, and A 450 greater than or equal to cut 168 off value was defined as a positive test. 169 2.4. Statistical analysis 170 Continuous variables were described in the form of means and standard deviations 171 or medians and interquartile ranges (IQR). Categorical variables were expressed as 172 counts and percentages. Independent group t tests were applied to continuous 173 variables that were normally distributed; otherwise, the Mann-Whitney test was used. 174 Categorical variables were compared using the chi-square tests, while the Fisher exact 175 test was used when data was limited. Statistical analyses were performed using 176 Statistical Package for the Social Sciences (SPSS) version 22.0 software.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Demographics and patient characteristics 181 Serum samples were collected from 238 admitted hospital patients with confirmed 182 or suspected SARS-CoV-2 infection in General Hospital of Central Theater Command 183 of PLA between February 6 to February 14, 2020. The clinical characteristics of the 184 patients are shown in Table 1. The median age was 55 years (IQR, 38.3-65), and 138 185 (58.0%) of the patients were men. Hypertension (63 [26.5%]), diabetes (25 [10.5%]), positive or negative results of real time RT-PCR assay for pharyngeal swab 191 specimens, the enrolled patients were divided into two groups: the confirmed group 192 and the suspected group. There were no statistical differences between the baseline 193 characteristics of the two patient groups.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "sample of 238 patients was tested for IgM and IgG antibodies against 197 SARS-CoV-2 using newly developed ELISA kits based on SARS-CoV-2 N protein. 198 The IgM and/or IgG were detected in 194 serum samples. The positive rate (81.5%) 199 was significantly higher than that of SARS-CoV-2 RNA detected using real time 200 RT-PCR, which was 64.3% (153/238) (Fig.1A). More importantly, there were no 201 significant differences in the positive rates of IgM and/or IgG between the confirmed 202 patients (83.0%, 127/153) and the suspected patients (78.8%, 67/85) (Fig.1B), 203 suggesting that the clinically suspected patients with negative viral RNA tests were 204 also mostly infected. 205 To verify the specificity of the ELISA assays, the serum samples from 70 randomly 206 selected ordinary patients and 50 healthy blood donors were simultaneously tested. 207 Four samples from the ordinary patients were identified as antibody positive (including one dual positive sample, two IgM-positive samples, and one IgG-positive 209 sample) and no positives were found in the samples from healthy blood donors 210(Fig.1A). These four patients had signs of pneumonia in chest imaging. One patient 211 had a negative viral nucleic acid test, and the other three patients were not tested for 212 viral nucleic acid. The specificity of antibody detection is 100% in healthy people and 213 94.3% in ordinary patients.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "216 especially in the early stages of the disease, we tried to analyze the positive rates of 217 ELISA and RT-PCR assays across the different stages of the disease. To this end, each 218 patient was assigned to different days after initial onset of symptoms based on the 219 time of blood collection for ELISA assays. For viral nucleic acid test, each patient was 220 assigned to different days after initial onset of symptoms based on the time when the 221 pharyngeal swab specimen was detected to be positive or the last recoded detection 222 was still negative. The positive rates of viral RNA, IgM, and/or IgG were compared in 223 every day after initial onset of symptoms",
            "latex": null,
            "type": "figure"
        },
        "FIGREF8": {
            "text": "ELISA and RT-PCR assays will greatly improve the detection efficacy, 243 even in the early stage of the COVIDof the recently emerged novel coronavirus (SARS-CoV-2) poses a 247 challenge for public health laboratories, especially for clinical laboratories in hospitals 248 in Wuhan, China. Although serological assay is a frequently used method for viral 249 infection screening and diagnosis, there are few reports on serological assay in the 250 detection of SARS-CoV-2. In this study, we evaluate the application of the 251 SARS-CoV-2 N protein-based ELISA for detection of IgM and IgG antibodies in admitted hospital patients with confirmed or suspected SARS-CoV-2 infections. The 253 results show that the positive rate of antibodies detected by ELISA was significantly 254 higher than that of viral RNA detected by real-time RT-PCR across all the enrolled 255 patients, suggesting that antibody detection is more sensitive than viral nucleic acid 256 test to diagnose SARS-CoV2 infection. More importantly, the suspected patients 257 exhibited nearly the same antibody detection rate as the confirmed patients. This data 258 strongly demonstrates that the majority of suspected patients, who were tested 259 negative for viral RNA, were in fact infected by SARS-CoV-2. 260 In this study, serum samples were collected in a time period of 9 days from 261 patients in different stages of the disease. The positive rates of nucleic acid test and 262 serological assay in total populations cannot reflect their diagnostic value in 263 surveillance and control of the disease. In order to objectively determine the disease 264 stage of the patients, we used the initial onset of symptoms exhibited by the patients 265 as the starting time point. All patients were defined to different stages of disease based 266 on when the test sample was collected. The dynamics patterns of positive rates of viral 267 RNA and antiviral antibodies confirmed the rationality of the definition of disease 268 stage. Our analysis identified the 11th day after initial onset of symptoms as a key 269 time point in the disease process. This is when most infected patients produce 270 antiviral antibodies. After the 11 th day, the diagnosis of viral infection should mainly 271 depend on serological assays. Before the 11 th day, the nucleic acid test is important for 272 confirmation of viral infection. The combination of serological assay and viral nucleic 273 acid test can greatly improve the diagnostic efficacy. Our conclusions closely align with that of to several recently published papers [depends on the positive results of nucleic acid tests or virus gene 279 sequencing. Despite being a preliminary ELISA assay for SARS-CoV-2, our study 280 strongly demonstrates that serological assays are key for the surveillance and control 281 of COVID-19, especially in epidemic areas where there is an abundance of .Z., S.W., and L.L. conceived the study and designed experimental procedures; tests. G.K.,W.L. W.N., and Y.Z established ELISA and performed 299 serological assays. S.W., L.L., S.Z., and W.L. wrote the paper. All authors contributed 300 to data acquisition, data analysis, or data interpretation, and reviewed and approved 301 the final version.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF9": {
            "text": "Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, 310 of novel coronavirus-infected pneumonia. N Engl J Med. 2020; 382(13):1199-1207. 311 [4] Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international 312 spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated 315 with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.316 Lancet. 2020; 395(10223):514-523. 317 [6] Peiris JS, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nat Med. 2004;10:S88-97. 318 [7] Lee J, Chowell G, Jung E. A dynamic compartmental model for the Middle East respiratory 319 syndrome outbreak in the Republic of Korea: A retrospective analysis on control interventions and 320 superspreading events. J Theor Biol. 2016;408:118-26. 321 [8] Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with 322 pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. 323 [9] Delmas B, Laude H. Assembly of coronavirus spike protein into trimers and its role in epitope 324 expression. J Virol. 1990;64:5367-75. 325 [10] Neuman BW, Kiss G, Kunding AH, Bhella D, Baksh MF, Connelly S, et al. A structural analysis of 326 M protein in coronavirus assembly and morphology. J Struct Biol. 2011;174:11-22. 327 [11] Nieto-Torres JL, DeDiego ML, Verdia-Baguena C, Jimenez-Guardeno JM, Regla-Nava JA, 328 Fernandez-Delgado R, et al. Severe acute respiratory syndrome coronavirus envelope protein ion 329 channel activity promotes virus fitness and pathogenesis. PLoS Pathog. 2014;10:e1004077. 330 [12] Chang CK, Sue SC, Yu TH, Hsieh CM, Tsai CK, Chiang YC, et al. Modular organization of SARS 331 coronavirus nucleocapsid protein. J Biomed Sci. 2006;13:59-72. 332 [13] Hurst KR, Koetzner CA, Masters PS. Identification of in vivo-interacting domains of the murine 333 coronavirus nucleocapsid protein. J Virol. 2009;83:7221-34. 334 [14] Cui L, Wang H, Ji Y, Yang J, Xu S, Huang X, et al. The nucleocapsid protein of coronaviruses acts 335 as a viral suppressor of RNA silencing in mammalian cells. J Virol. 2015;89:9029-43. 336 [15] Narayanan K, Chen CJ, Maeda J, Makino S. Nucleocapsid-independent specific viral RNA 337 packaging via viral envelope protein and viral RNA signal. J Virol. 2003;77:2922-7. 338 [16] Che XY, Qiu LW, Pan YX, Wen K, Hao W, Zhang LY, et al. Sensitive and specific monoclonal 339 antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from 340 patients with severe acute respiratory syndrome. J Clin Microbiol. 2004;42:2629-35. 341 [17] Guan M, Chen HY, Foo SY, Tan YJ, Goh PY, Wee SH. Recombinant protein-based enzyme-linked 342 immunosorbent assay and immunochromatographic tests for detection of immunoglobulin G antibodies 343 to severe acute respiratory syndrome (SARS) coronavirus in SARS patients. Clin Diagn Lab Immunol.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF10": {
            "text": "Figure legends",
            "latex": null,
            "type": "figure"
        },
        "FIGREF11": {
            "text": "Positive rate of viral RNA and antibody in different samples. A) The 370 positive rate of viral RNA (black column) and antibody (white column) in 238 371 enrolled patients (two columns on the left), as well as the positive rate of antibody in 372 ordinary patients and healthy donors (two columns on the right). B) Comparison of 373 positive rate of antibody between the laboratory-confirmed (left) and highly-suspected 374 patients (right). Results were compared by chi-square tests. 375 Dynamics of the positive rate of viral RNA and antibody of the patients 377 at the different stages of disease. The disease courses were divided into five phases 378 of 0-5, 6-10,11-12, 13-15 days and more than 16 days after initial onset of symptoms. 379 The positive rate of viral RNA (solid circle) and antibody (hollow circle) of the 380 patients at the different phase of disease was shown.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF13": {
            "text": "Figure 1",
            "latex": null,
            "type": "figure"
        },
        "FIGREF14": {
            "text": "Figure 2",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "). The S protein homotrimers are required for attachment to host 69 receptors [9], and both the M protein and the E protein play important roles in 70 virus assembly [10,11]. The N protein is responsible for packaging the encapsidated 71 genome into virions [12,13], and acts as a viral RNA silencing suppressor that is 72 beneficial for the viral replication [14]. Furthermore, the N protein has high73 immunogenic activity and is profusely overexpressed during infection [15]. Thus, the 74 N protein is a potential source of diagnostic antigen for detecting the SARS-CoV-2 75 infection. Many diagnostic methods based on the N protein have been developed for detecting SARS-CoV [16-18]. In addition, different CoVs possess special structural 77 and accessory proteins, such as the HE protein, 3a/b protein, and 4a/b protein [19]. Both nucleic acid tests and serological assays are commonly used for infectious 79 disease screening and diagnosis. In the present case of SARS-CoV-2 in China, nucleic 80 acid tests are routinely used to detect causative viruses from respiratory secretions 81 using real-time RT-PCR. However, the nucleic acid tests appear to have a high false 82 negative rate due to various unavoidable factors, including the sensitivity of the 83 detection kits, and the sampling location and technique [20]. A large number of 84 clinically-suspected patients, whose nucleic acid tests are negative, are unable to get 85 timely hospitalization, potentially promoting the spread of SARS-CoV-2 and disease 86 progression of suspected patients. In this study, a newly-developed IgM and IgG antibod detecting Enzyme-linked 88 immunosorbent assays (ELISA) based on a recombinant fragment of the SARS-CoV-2 N protein was used to detect IgM and IgG against SARS-CoV-2 in the 90 serums of 238 admitted hospital patients with confirmed or suspected SARS-CoV-2 91 infections. The results strongly indicate that the suspected patients were in fact 92 infected. We also analyzed the diagnostic value of the IgM and IgG testing in COVID-19, even in the early stages of the disease. All consecutive patients (n=238) with confirmed or suspected SARS-CoV-2 infections who have been tested using real-time RT-PCR for viral infections and were 99 treated in General Hospital of Central Theater Command of PLA between February 6",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Demographic and baseline characteristics of 238 enrolled patients",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "Viral RNA and antibody positive rates of the patients detected each day from initial onset of symptoms",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "Viral RNA and antibody positive rates of the patients detected in different stages of disease",
            "latex": null,
            "type": "table"
        },
        "TABREF4": {
            "text": "Comparison of the antibody positive rates between the confirmed and suspected patientsData are % (n/N). Confirmed=confirmed patients. Suspected=suspected patients.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}